196 related articles for article (PubMed ID: 30342822)
1. Protease inhibitors broadly effective against feline, ferret and mink coronaviruses.
Perera KD; Galasiti Kankanamalage AC; Rathnayake AD; Honeyfield A; Groutas W; Chang KO; Kim Y
Antiviral Res; 2018 Dec; 160():79-86. PubMed ID: 30342822
[TBL] [Abstract][Full Text] [Related]
2. Broad-spectrum inhibitors against 3C-like proteases of feline coronaviruses and feline caliciviruses.
Kim Y; Shivanna V; Narayanan S; Prior AM; Weerasekara S; Hua DH; Kankanamalage AC; Groutas WC; Chang KO
J Virol; 2015 May; 89(9):4942-50. PubMed ID: 25694593
[TBL] [Abstract][Full Text] [Related]
3. Potent inhibition of feline coronaviruses with peptidyl compounds targeting coronavirus 3C-like protease.
Kim Y; Mandadapu SR; Groutas WC; Chang KO
Antiviral Res; 2013 Feb; 97(2):161-8. PubMed ID: 23219425
[TBL] [Abstract][Full Text] [Related]
4. Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor.
Kim Y; Liu H; Galasiti Kankanamalage AC; Weerasekara S; Hua DH; Groutas WC; Chang KO; Pedersen NC
PLoS Pathog; 2016 Mar; 12(3):e1005531. PubMed ID: 27027316
[TBL] [Abstract][Full Text] [Related]
5. Characterization of amino acid substitutions in feline coronavirus 3C-like protease from a cat with feline infectious peritonitis treated with a protease inhibitor.
Perera KD; Rathnayake AD; Liu H; Pedersen NC; Groutas WC; Chang KO; Kim Y
Vet Microbiol; 2019 Oct; 237():108398. PubMed ID: 31585653
[TBL] [Abstract][Full Text] [Related]
6. Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses.
Kim Y; Lovell S; Tiew KC; Mandadapu SR; Alliston KR; Battaile KP; Groutas WC; Chang KO
J Virol; 2012 Nov; 86(21):11754-62. PubMed ID: 22915796
[TBL] [Abstract][Full Text] [Related]
7. Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses.
Theerawatanasirikul S; Kuo CJ; Phecharat N; Chootip J; Lekcharoensuk C; Lekcharoensuk P
Antiviral Res; 2020 Oct; 182():104927. PubMed ID: 32910955
[TBL] [Abstract][Full Text] [Related]
8. Adaptive Mutation in the Main Protease Cleavage Site of Feline Coronavirus Renders the Virus More Resistant to Main Protease Inhibitors.
Jiao Z; Yan Y; Chen Y; Wang G; Wang X; Li L; Yang M; Hu X; Guo Y; Shi Y; Peng G
J Virol; 2022 Sep; 96(17):e0090722. PubMed ID: 36000844
[TBL] [Abstract][Full Text] [Related]
9. Picornaviral 3C protease inhibitors and the dual 3C protease/coronaviral 3C-like protease inhibitors.
Wang HM; Liang PH
Expert Opin Ther Pat; 2010 Jan; 20(1):59-71. PubMed ID: 20021285
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-like protease inhibitors.
Ramajayam R; Tan KP; Liu HG; Liang PH
Bioorg Med Chem; 2010 Nov; 18(22):7849-54. PubMed ID: 20947359
[TBL] [Abstract][Full Text] [Related]
11. α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment.
Zhang L; Lin D; Kusov Y; Nian Y; Ma Q; Wang J; von Brunn A; Leyssen P; Lanko K; Neyts J; de Wilde A; Snijder EJ; Liu H; Hilgenfeld R
J Med Chem; 2020 May; 63(9):4562-4578. PubMed ID: 32045235
[TBL] [Abstract][Full Text] [Related]
12. Assessing activity and inhibition of Middle East respiratory syndrome coronavirus papain-like and 3C-like proteases using luciferase-based biosensors.
Kilianski A; Mielech AM; Deng X; Baker SC
J Virol; 2013 Nov; 87(21):11955-62. PubMed ID: 23986593
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances in the Discovery of Potent Proteases Inhibitors Targeting the SARS Coronaviruses.
Sharma A; Kaliya K; Maurya SK
Curr Top Med Chem; 2021; 21(4):307-328. PubMed ID: 33183205
[TBL] [Abstract][Full Text] [Related]
14. Development of a red-shifted fluorescence-based assay for SARS-coronavirus 3CL protease: identification of a novel class of anti-SARS agents from the tropical marine sponge Axinella corrugata.
Hamill P; Hudson D; Kao RY; Chow P; Raj M; Xu H; Richer MJ; Jean F
Biol Chem; 2006 Aug; 387(8):1063-74. PubMed ID: 16895476
[TBL] [Abstract][Full Text] [Related]
15. Two Inhibitors Against the 3C-Like Proteases of Swine Coronavirus and Feline Coronavirus.
Zhou M; Han Y; Li M; Ye G; Peng G
Virol Sin; 2021 Dec; 36(6):1421-1430. PubMed ID: 34228261
[TBL] [Abstract][Full Text] [Related]
16. Crystal Structure of Feline Infectious Peritonitis Virus Main Protease in Complex with Synergetic Dual Inhibitors.
Wang F; Chen C; Liu X; Yang K; Xu X; Yang H
J Virol; 2016 Feb; 90(4):1910-7. PubMed ID: 26656689
[TBL] [Abstract][Full Text] [Related]
17. In silico and in vitro analysis of small molecules and natural compounds targeting the 3CL protease of feline infectious peritonitis virus.
Theerawatanasirikul S; Kuo CJ; Phetcharat N; Lekcharoensuk P
Antiviral Res; 2020 Feb; 174():104697. PubMed ID: 31863793
[TBL] [Abstract][Full Text] [Related]
18. High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase.
Blanchard JE; Elowe NH; Huitema C; Fortin PD; Cechetto JD; Eltis LD; Brown ED
Chem Biol; 2004 Oct; 11(10):1445-53. PubMed ID: 15489171
[TBL] [Abstract][Full Text] [Related]
19. Coronaviruses resistant to a 3C-like protease inhibitor are attenuated for replication and pathogenesis, revealing a low genetic barrier but high fitness cost of resistance.
Deng X; StJohn SE; Osswald HL; O'Brien A; Banach BS; Sleeman K; Ghosh AK; Mesecar AD; Baker SC
J Virol; 2014 Oct; 88(20):11886-98. PubMed ID: 25100843
[TBL] [Abstract][Full Text] [Related]
20. X-ray structure and inhibition of the feline infectious peritonitis virus 3C-like protease: Structural implications for drug design.
St John SE; Therkelsen MD; Nyalapatla PR; Osswald HL; Ghosh AK; Mesecar AD
Bioorg Med Chem Lett; 2015 Nov; 25(22):5072-7. PubMed ID: 26592814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]